Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01646008
Other study ID # Carbon dioxide Getafe
Secondary ID
Status Completed
Phase N/A
First received July 18, 2012
Last updated December 2, 2015
Start date April 2012
Est. completion date August 2013

Study information

Verified date December 2015
Source Hospital Universitario Getafe
Contact n/a
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Observational

Clinical Trial Summary

The purpose of this study is to study the correlation between carbon dioxide measured by capnography at the enf of exhalation and arterial blood in COPD patients with nasal cannula in critical care unit.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date August 2013
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults

- COPD patients

Exclusion Criteria:

- Under-aged

- Pregnant

- Major burns

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms

  • Correlation Between Exhaled Carbon Dioxide and in Arterial Blood
  • Pulmonary Disease, Chronic Obstructive

Intervention

Other:
To measure carbon dioxide by capnography and arterial blood
Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.
to measure carbon dioxide by capnography and arterial blood
three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography

Locations

Country Name City State
Spain Hospital Universitario de Getafe Getafe Madrid

Sponsors (1)

Lead Sponsor Collaborator
Hospital Universitario Getafe

Country where clinical trial is conducted

Spain,